Press Releases
Here is a selection of recent PharmaVentures press releases...
New Industry Dynamics to Help Secure the Right Deal
Oxford, UK- June 27 2011 - PharmaDeals®, the publishing division of PharmaVentures, announced today the launch of PharmaDeals v4 Enterprise Edition, a new integrated resource with a comprehensive, searchable and interactive library of reports, articles, agreements, video, graphs and deal data. As well as access to new online content, the resource also provides users with a range of applications and tools for tracking, alerting and analysing information.
PharmaVentures Corporate Advisory appoints Ping Shek as Senior Director in Transactions
PharmaVentures today announced the appointment of Ping Shek as Senior Director in the Transactions division of Corporate Advisory working on a number of key M&A and divestment mandates in the healthcare business sector.
PharmaVentures facilitates manufacturing divestment for UCB to Aesica Pharmaceuticals
Oxford, UK. 01 March 2011 - PharmaVentures Ltd acted as exclusive advisor and broker to the global biopharma company, UCB in its successful strategic partnership with UK-based developer and manufacturer Aesica Pharmaceuticals.
PharmaDeals Research Reveals Early Signs of Recovery in Pharma Industry Deal Making
Oxford, UK, 22nd February 2011: PharmaDeals® research has revealed that the early stages of recovery are now evident within pharmaceutical deal making activity. The overall number of deals in 2010 grew relative to 2009, and whilst collaborative R&D deals continue to decline in numbers and value, licensing activity is on the increase.